Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2010

Nov 16, 2010

32870_dirs_2010-11-16_ed13aec6-5603-4043-bddd-6bea81e70848.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2010-11-11

Reporting Person: LOCKHART STEPHEN (SVP Product Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-11 Common Stock M 16666 $10.38 Acquired 23646 Direct
2010-11-11 Common Stock M 11667 $10.68 Acquired 35313 Direct
2010-11-11 Common Stock S 28333 $18.66 Disposed 6980 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-11 Employee Stock Option (right to buy) $10.38 M 16666 Disposed 2014-10-19 Common Stock (16666) Direct
2010-11-11 Employee Stock Option (right to buy) $10.68 M 11667 Disposed 2015-08-11 Common Stock (11667) Direct

Footnotes

F1: The option vested in three equal installments on October 19, 2008, 2009, and 2010.

F2: The option vested in two equal installments on August 11, 2009, and 2010; the remainder will vest on August 11, 2011.